NetworkNewsBreaks – CytoDyn Inc. (CYDY) Appoints New Member to Board of Directors
Jan 10, 2019
Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced the appointment of David F. Welch, Ph.D., Founder, Chief Innovation Officer and Director of Infinera Corporation, to the CytoDyn Board of Directors. Dr. Welch has a notable background including strategic planning expertise and broad capital markets experience. As an investor in the company, he appreciates the potential of CYDY’s leronlimab in targeting multiple disease processes. “We are pleased to add Dr. Welch to our Board of Directors. He is a pioneer in the field of optical devices and optical transport with a strong scientific background,” CytoDyn president and CEO Dr. Nader Pourhassan stated in the news release. “Dr. Welch has an inventor’s heart with over 130 patents and 250 published articles to his name. We anticipate he will be a strong contributor to our strategic planning.”
To view the full press release, visit http://nnw.fm/4C3Mz
About CytoDyn
CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab (PRO 140), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells. The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with leronlimab in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The company plans to seek FDA approval for leronlimab in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first half of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with leronlimab as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of leronlimab monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that leronlimab can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that leronlimab monotherapy can prevent viral escape in HIV-infected patients, with some patients on leronlimab monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate leronlimab for the prevention of GvHD and initiated a clinical trial with leronlimab in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com.
More from NetworkNewsBreaks
NetworkNewsBreaks – QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Reports Positive MMI Geochemical Orientation Survey Results NetworkNewsBreaks – Sharing Services, Inc. (SHRV) Names New Chief Marketing Officer of Elepreneur, LLC. NetworkNewsBreaks – The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) Gains Conditional Approval for Listing on the Toronto Stock ExchangeAbout NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]
NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.
More News
G7 to release millions of barrels of oil and diesel after Trump threat
The co-ordinated release is aimed at heading off further price spikes and avoiding a ban on US diesel exports.
White House Filing Claims President Has Authority to Bar News Outlets
The Trump administration again defended the decision to bar CNN, MS NOW and Politico from the White House and to exclude journalists from the pool that covers the president in small spaces.
Federal Watchdog Investigates Adam Kinzinger for Kalshi Bets on His Pardon
The inquiry by the Commodity Futures Trading Commission centers on bets the former congressman made on Kalshi in the weeks before he was pardoned in January 2025.
US Sanctions A7, a Russia Firm That Helps Sidestep Economic Restrictions
The move followed reports detailing how A7, a Moscow firm, uses shell companies around the world to move funds for clients who are themselves subject to sanctions.
G20 trade ministers meet in Wisconsin amid trade tensions
G20 trade ministers meet in Wisconsin amid trade tensions
Chinese manufacturers dominate Latin America's bus fleet
Chinese manufacturers dominate Latin America's bus fleet
F.D.A. Found Cyclospora During Taylor Farms Inspection in Mexico
The discovery adds strong evidence that the outbreak that sickened thousands over the summer originated in a grower’s field or processing facility.
The Powerful Yet Fragile Force Propping Up Stocks and the Economy
The artificial intelligence boom has pushed up the stock market, even as interest rates have pulled it down, our columnist says.
Mash-Up of Paramount and Warner Bros. Will Be Called Skydance
David Ellison, the tech scion who will run the combined company, borrowed the name of his original entertainment company that reflects his love of aviation. On Friday, the C.E.O.s of Warner Bros. were told they would not stay on once the companies merged.
U.S. and Allies Agree to Release Diesel Reserves as Prices Soar
The Group of 7, which includes Britain, France and Japan, announced the release of 100 million barrels over four months, effective immediately.
Sales of Hulking Pickups and S.U.V.s Sag as Fuel Prices Soar
Sales of big pickup trucks and sport utility vehicles have dipped as more Americans buy hybrids and smaller cars.
Hiring Slows as U.S. Jobs Report Shows Labor Market Shifting Into Lower Gear
The economy added fewer jobs in September and unemployment ticked up, while inflation has maintained pressure on markets and raised costs.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.